MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Outpatient Treatment of Functional Movement Disorders

D. Hinkle, S. Patel, A. Husted, B. Darrah, B. Bettonville, C. Sabbagh (Columbus, USA)

Meeting: 2024 International Congress

Abstract Number: 409

Keywords: Psychogenic movement disorders(PMD): Treatment

Category: Functional Movement Disorders / Psychogenic Movement Disorders

Objective: To assess the capacity of an outpatient-based functional movement disorders (FMD) treatment program to reduce FMD symptoms.

Background: FMDs are common, intrusive, and systemically expensive, but potentially treatable disorders for which few clinics deliver dedicated treatment (e.g., beyond diagnosis and disease education). Intensive inpatient programs combining cognitive behavioral and motor retraining therapies have successfully treated FMDs. However, this model is difficult to implement in the “real world” due to logistical and economical constraints. We emulated published inpatient FMD treatment trials with an outpatient program which was relatively easy to deliver and covered by insurance.

Method: Two movement disorders neurologists provided FMD diagnosis and education. Patients were then referred to an overlapping program of 4 continuous weeks of outpatient cognitive behavioral therapy (2-3 sessions/week with a psychologist) run simultaneously with 4 continuous weeks of outpatient motor retraining therapy (2-3 sessions/week with physical and occupational therapists). Pre- and post-treatment Movement Disorder Society “Psychogenic Movement Disorders Rating Scale” (PMDRS) scores were recorded, and patients were interviewed post-treatment about their experience.

Results: Of the FMD patients that completed the outpatient treatment program, more than 80% responded with at least a 70% reduction in their PMDRS score. Three patients reported complete symptomatic resolution. The vast majority reported that the program was valuable with regard to learning how to understand and control symptoms.

Conclusion: Outpatient treatment with combined, intensive cognitive behavioral and motor retraining therapies can reduce and, in some cases, eliminate FMD symptoms. The outpatient approach is more feasible than the inpatient with regard to “real world” logistics and insurance coverage. Although our therapeutic success rate was high, it was skewed heavily towards patients who “bought in” to and completed our treatment program. Many patients found our current approach to be too time-intensive; of those most chose not to participate, whereas others quit mid-program. Future endeavors will focus on optimizing therapeutic benefit with better time economy for both patients and clinicians.

To cite this abstract in AMA style:

D. Hinkle, S. Patel, A. Husted, B. Darrah, B. Bettonville, C. Sabbagh. Outpatient Treatment of Functional Movement Disorders [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/outpatient-treatment-of-functional-movement-disorders/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/outpatient-treatment-of-functional-movement-disorders/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley